U.S. Wireless Telecom Stock News

NYSE:NVT
NYSE:NVTElectrical

nVent Electric (NVT) Stock Looks Above Fair Value With Cash Flow And Earnings Both Rich

nVent Electric stock has delivered a very strong 443.0% return over the past 5 years, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a premium. With the stock at US$158.47 after a recent pullback, the valuation tests raise questions about how much upside is already priced in. Over 5 years, nVent Electric has returned 443.0%, which puts long term holders in a strong position but also raises the bar for future...
NYSE:FN
NYSE:FNElectronic

Fabrinet (FN) Falls 17% In A Month, Is It Cheap Or Fully Valued?

Fabrinet (FN) has drawn investor attention after recent trading saw the stock fall 2.6% in one day and decline about 16.8% over the past month, despite a strong longer term track record. See our latest analysis for Fabrinet. At a share price of $513.67, Fabrinet’s 1 day share price return of 2.59% and 30 day share price return of 16.76% suggest momentum has cooled recently. However, the 1 year total shareholder return of 68.31% highlights how strong longer term returns have been. If...
NYSE:AVNS
NYSE:AVNSMedical Equipment

Avanos Medical (AVNS) Rebounds Sharply, Is The Stock Above Fair Value?

Avanos Medical (AVNS) continues to trade around $24.98, drawing attention from investors who are weighing its medical device portfolio against mixed financial metrics, including modest annual revenue growth and a reported net loss. See our latest analysis for Avanos Medical. Over the past year Avanos Medical’s share price return has moved sharply higher, with a year to date share price return of 123.43% and a 1 year total shareholder return of 106.28%. However, the 5 year total shareholder...
NasdaqGS:DFTX
NasdaqGS:DFTXPharmaceuticals

Is Definium Therapeutics (DFTX) Expensive As New GAD Study Sharpens Its Late Stage Case?

Definium Therapeutics (DFTX) is back in focus after releasing a large U.S. healthcare claims study on generalized anxiety disorder. The study highlights frequent treatment discontinuation, switching, and long therapy gaps for both newly diagnosed and established patients. See our latest analysis for Definium Therapeutics. Against this backdrop, Definium Therapeutics shares have cooled in the very short term, with a 1-day share price return of 3.13% and a 7-day share price return of 4.36%...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA) Helps Power DoorDash Crimson Instant Deposits With Mastercard Send

DoorDash introduced instant deposits for DoorDash Crimson using Mastercard Send. The rollout uses Astra's Payments Cloud to enable real-time payouts to eligible users. The partnership extends Mastercard's reach into gig economy payouts beyond traditional card transactions. This new DoorDash Crimson feature puts Mastercard (NYSE:MA) directly into the flow of real-time earnings for gig workers by connecting Mastercard Send with Astra's Payments Cloud to move funds quickly. For readers...
NYSE:FOUR
NYSE:FOURDiversified Financial

Shift4 Payments (FOUR) Stock Still Looks Pricey On Its Shift4 One Launch

Shift4 Payments stock has had a tough 12 months, with the share price under pressure while the Excess Returns intrinsic value estimate sits close to the current market level and earnings based multiples still point to a premium. That tension, combined with a low overall value score, is keeping the debate open on whether today’s price fairly reflects the risks around the story. Over the past year, Shift4 Payments shares have declined 54.8%, which means recent investors have taken a...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Is Repeated Earnings Outperformance Altering The Investment Case For GLOBALFOUNDRIES (GFS)?

Earlier this month, analysts highlighted that GlobalFoundries Inc. (GFS) has recently outperformed earnings estimates and was anticipated to potentially beat expectations again in its upcoming August 5, 2026 report, supported by a positive Earnings ESP and a Zacks Rank #3 (Hold). An interesting angle is how this pattern of earnings outperformance may be influencing market confidence in GlobalFoundries’ ability to execute operationally despite a mixed recent return profile. With expectations...
NYSE:ALX
NYSE:ALXRetail REITs

Is Alexander's (ALX) Fully Valued Following Its Latest Results?

Alexander's (ALX) continues to draw attention after recent share price moves alongside its latest reported figures, including US$211.68 million in revenue and US$20.57 million in net income from its New York focused real estate portfolio. See our latest analysis for Alexander's. At a latest share price of US$276.53, Alexander's has seen a 26.35% year to date share price return and a 16.80% total shareholder return over the past year, with the recent 1 day decline of 3.35% tempering what has...
NYSE:RACE
NYSE:RACEAuto

Ferrari (RACE) Could Be 13% Below Fair Value As Its Growth Narrative Builds

Ferrari (NYSE:RACE) is back in focus after recent share price moves, with the stock closing at $371.61. The company’s luxury sports car and lifestyle ecosystem gives investors several angles to assess potential risk and reward. See our latest analysis for Ferrari. Ferrari’s recent 1 month share price return of 6.66% and 3 month gain of 4.92% contrast with a flat year to date move and a 1 year total shareholder return that declined 27.37%. This suggests that shorter term momentum has picked up...
NasdaqGS:SEIC
NasdaqGS:SEICCapital Markets

SEI Investments (SEIC) Buybacks Keep Valuation In Focus

SEI Investments (SEIC) has drawn investor attention after updating its long running share repurchase program, confirming that it bought 1,300,000 shares for US$112.4 million in the quarter and has now completed 83.92% of the authorized buyback. See our latest analysis for SEI Investments. The updated buyback comes alongside a solid run in SEI Investments' stock, with a year to date share price return of 18.96% and longer term total shareholder returns of 60.61% over three years and 73.86%...
NYSE:CDE
NYSE:CDEMetals and Mining

Coeur Mining (CDE) Exploration Push Puts Its Undervalued Narrative Back In Focus

Coeur Mining (CDE) is drawing fresh attention after announcing a record US$158 million exploration budget for 2026, focused on its Palmarejo and Las Chispas gold and silver operations in Mexico. See our latest analysis for Coeur Mining. At a share price of US$15.84, Coeur Mining has seen its 30 day share price return fall 9.33% and its 90 day share price return fall 16.01%, even as the 1 year total shareholder return sits at 66.75% and the 3 year total shareholder return is very large at...
NYSE:ALV
NYSE:ALVAuto Components

Autoliv (ALV) Could Be 11% Below Fair Value On Q2 Earnings And Buybacks

Autoliv (ALV) is in focus after reporting second quarter 2026 earnings that paired higher sales with lower net income, along with completing a sizeable share repurchase program that retired nearly 5% of its stock. See our latest analysis for Autoliv. At a share price of $119.01, Autoliv’s recent 1 day share price return of 1.28% and 1 year total shareholder return of 4.67% suggest modest upward momentum, supported by the latest earnings release and the completion of the buyback program, which...
NYSE:MYE
NYSE:MYEPackaging

3 Small Cap Stocks Trading Below Fair Value As Rate Cuts Come Into View

Small caps sit at the crossroads of several powerful forces right now, from a US equity market trading at an 8% discount to fair value to shifting views on inflation, interest rates, and credit risk. For investors willing to look beyond the largest technology and AI stocks, this mix of lower valuations and changing macro conditions can create both opportunities and traps. This article breaks down what the recent news on inflation, Federal Reserve policy, and credit markets could mean for...
NYSE:HUM
NYSE:HUMHealthcare

Humana (HUM) Could Be 87% Overvalued On Earnings Beat Expectations

Humana (HUM) is back in focus after recent analyst updates pointed to the possibility of upcoming quarterly earnings beating consensus estimates, with a positive Earnings ESP and strong buy ratings drawing investor attention. See our latest analysis for Humana. Humana's share price has had a strong run recently, with a 30 day share price return of 10.22% and a 90 day share price return of 84.97%, while the 1 year total shareholder return of 70.10% contrasts with weaker 3 and 5 year total...
NYSE:CVI
NYSE:CVIOil and Gas

Is CVR Energy (CVI) Overvalued Following Earnings Growth Expectations?

CVR Energy (CVI) is in focus as investors look ahead to the July 29 earnings report, with Wall Street expecting year-over-year growth in both earnings and revenues for the June 2026 quarter. See our latest analysis for CVR Energy. At a share price of $34.88, CVR Energy has logged a 30 day share price return of 25.02% and a year to date share price return of 38.47%. The 5 year total shareholder return of 252.87% points to strong long term compounding, suggesting recent momentum has picked up...
NasdaqGS:MMYT
NasdaqGS:MMYTHospitality

Is MakeMyTrip (MMYT) Cheap As Analyst Upgrades Lift Its Valuation Narrative?

MakeMyTrip (MMYT) has been back in focus after analysts raised earnings estimates in unison, coupled with a top-tier ranking from Zacks that has coincided with fresh momentum in the stock. See our latest analysis for MakeMyTrip. That optimism has been tested in the short term, with MakeMyTrip’s share price falling 8.6% over the last day and 6.5% over the past week, even after a 12.0% 30 day share price return and 13.2% 90 day share price return. These sit against a year to date share price...
NasdaqGS:CEVA
NasdaqGS:CEVASemiconductor

How Does CEVA’s (CEVA) COO Transition Shape Its Edge AI Execution Story?

CEVA, Inc. disclosed that Executive Vice President and Chief Operating Officer Michael Boukaya agreed to resign his role on August 1, 2026, while remaining with the company through December 31, 2026 to support a transition. This leadership change raises questions about how CEVA will sustain operational execution as it pursues growth in Edge AI and wireless IP licensing. Next, we’ll examine how Michael Boukaya’s planned departure as Chief Operating Officer may affect CEVA’s Edge AI-driven...
NYSE:ELF
NYSE:ELFPersonal Products

e.l.f. Beauty (ELF) Stock Looks Rich Relative To Fair Value

e.l.f. Beauty stock has nearly tripled over the past five years, yet its current checks lean expensive. This raises the question of whether the recent weakness in the share price has already been priced fairly or still leaves investors paying a premium. e.l.f. Beauty has returned about 196.0% over five years, which puts the recent 1 year and 3 year share price declines into the context of a much stronger longer term run. Expectations for continued brand reach and product demand can support...
NYSE:IRT
NYSE:IRTResidential REITs

Independence Realty Trust (IRT) Trades Below Fair Value, Is The Upside Worth The Risks?

Independence Realty Trust (IRT) has attracted investor attention after recent trading left the stock around $16.35, with performance mixed across different time frames and return trends diverging over the past year and past 3 months. See our latest analysis for Independence Realty Trust. For Independence Realty Trust, the recent 1 month share price return of 2.12% and 3 month share price return of 3.15% sit against a year to date share price decline of 7.10%. The 1 year total shareholder...
NYSE:ICE
NYSE:ICECapital Markets

Is ICE’s Blockchain Joint Venture With OKX Quietly Reframing the Digitization Narrative for Intercontinental Exchange (ICE)?

Earlier this week, former New York Gov. Andrew Cuomo discussed his role on the board of crypto exchange OKX following its joint venture with Intercontinental Exchange (ICE), highlighting plans to apply blockchain technology to financial market infrastructure. Cuomo’s comments framed blockchain as potential “future rails” for markets, underscoring how ICE may be exploring technology that could make trading and settlement faster, cheaper and more efficient across its platforms. Next, we’ll...
NYSE:ATI
NYSE:ATIAerospace & Defense

Should ATI’s US$80 Million Mexico Bet Reshape How Investors View ATI (ATI)’s Global Strategy?

ATI Materials has invested US$80,000,000 to establish ATI Forged Products in Chihuahua City, Mexico, creating over 230 specialized forging and manufacturing jobs to support high-tech global supply chains. This move deepens ATI’s role in aerospace- and defense-related advanced materials while reinforcing Chihuahua’s position as a key aerospace manufacturing hub in Mexico. We’ll now explore how ATI’s new Chihuahua forging division and its advanced manufacturing focus could influence the...
NYSE:NOG
NYSE:NOGOil and Gas

Is Northern Oil And Gas (NOG) Cheap As Buybacks And Guidance Reset Its Valuation?

Northern Oil and Gas (NOG) is back in focus after issuing fresh second quarter 2026 production guidance, updating investors on an expanded share repurchase program, and detailing recent buyback activity. See our latest analysis for Northern Oil and Gas. Northern Oil and Gas shares trade at $22.05, and recent buyback news and production guidance appear to have coincided with a 14.19% 1-month share price return. However, the 1-year total shareholder return is down 15.28% and the 3-year total...
NasdaqGS:JBHT
NasdaqGS:JBHTTransportation

Is J.B. Hunt Transport Services (JBHT) Fully Valued After Strong Earnings And AI Freight Progress?

J.B. Hunt Transport Services (JBHT) is back in focus after reporting second quarter results that included higher revenue, net income and earnings per share, along with record intermodal volumes and increased use of AI driven freight technology. See our latest analysis for J.B. Hunt Transport Services. Those strong second quarter figures, the new AI freight execution rollout with Overroute, recent buybacks and a fresh dividend declaration have coincided with a 90 day share price return of...
NYSE:CAH
NYSE:CAHHealthcare

Cardinal Health (CAH) Is Buying Strive Medical And AdaptHealth Diabetes Business

Cardinal Health (NYSE:CAH) has agreed to acquire Strive Medical, a provider of urology and wound care supplies for patients at home. The company is also buying AdaptHealth’s diabetes business, adding to its at-Home Solutions division. Both deals focus on expanding Cardinal Health’s home care offering in diabetes management and urology. The transactions are expected to be accretive to non-GAAP earnings within a year of closing. Cardinal Health enters these transactions with its stock at...